These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
457 related articles for article (PubMed ID: 37841237)
1. Identification of specific prognostic markers for lung squamous cell carcinoma based on tumor progression, immune infiltration, and stem index. Wu R; Ma R; Duan X; Zhang J; Li K; Yu L; Zhang M; Liu P; Wang C Front Immunol; 2023; 14():1236444. PubMed ID: 37841237 [TBL] [Abstract][Full Text] [Related]
2. Significance of Lin H; Wang J; Shi Q; Wu M PeerJ; 2024; 12():e17338. PubMed ID: 38708353 [TBL] [Abstract][Full Text] [Related]
3. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma. Li N; Li Y; Zheng P; Zhan X Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015 [TBL] [Abstract][Full Text] [Related]
4. A 13-gene signature to predict the prognosis and immunotherapy responses of lung squamous cell carcinoma. Yang Q; Gong H; Liu J; Ye M; Zou W; Li H Sci Rep; 2022 Aug; 12(1):13646. PubMed ID: 35953696 [TBL] [Abstract][Full Text] [Related]
5. Identification of Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma. Li N; Wang J; Zhan X Front Immunol; 2021; 12():752643. PubMed ID: 34887858 [TBL] [Abstract][Full Text] [Related]
6. A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma. Zhou H; Zhang H; Shi M; Wang J; Huang Z; Shi J Int Immunopharmacol; 2020 Nov; 88():106856. PubMed ID: 32777677 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive analyses of a CD8 Chen L; Weng Y; Cui X; Li Q; Peng M; Song Q BMC Bioinformatics; 2023 Jun; 24(1):238. PubMed ID: 37280525 [TBL] [Abstract][Full Text] [Related]
8. Development and validation of a novel immune-related prognostic signature in lung squamous cell carcinoma patients. Liu X; Zhao D; Shan Y; Cui W; Xie Q; Jiang J; Peng W; Zhang C; Duan C Sci Rep; 2022 Dec; 12(1):20737. PubMed ID: 36456645 [TBL] [Abstract][Full Text] [Related]
9. A Novel Immune-Related Seventeen-Gene Signature for Predicting Early Stage Lung Squamous Cell Carcinoma Prognosis. Fan T; Lu Z; Liu Y; Wang L; Tian H; Zheng Y; Zheng B; Xue L; Tan F; Xue Q; Gao S; Li C; He J Front Immunol; 2021; 12():665407. PubMed ID: 34177903 [TBL] [Abstract][Full Text] [Related]
10. Risk stratification and prognosis prediction based on inflammation-related gene signature in lung squamous carcinoma. Zhai W; Chen S; Duan F; Wang J; Zhao Z; Lin Y; Rao B; Wang Y; Zheng L; Long H Cancer Med; 2023 Feb; 12(4):4968-4980. PubMed ID: 36056909 [TBL] [Abstract][Full Text] [Related]
11. Effects of Lipid Metabolism-Related Genes PTGIS and HRASLS on Phenotype, Prognosis, and Tumor Immunity in Lung Squamous Cell Carcinoma. Lei K; Liang R; Tan B; Li L; Lyu Y; Wang K; Wang W; Wang K; Hu X; Wu D; Lin H; Wang M Oxid Med Cell Longev; 2023; 2023():6811625. PubMed ID: 36703911 [TBL] [Abstract][Full Text] [Related]
12. Construction and Validation of Prognostic Regulation Network Based on RNA-Binding Protein Genes in Lung Squamous Cell Carcinoma. Zhao S; Liu Q; Li J; Hu C; Cao F; Ma W; Gao J DNA Cell Biol; 2021 Dec; 40(12):1563-1583. PubMed ID: 34931870 [TBL] [Abstract][Full Text] [Related]
13. Pyroptosis-related long-noncoding RNA signature predicting survival and immunotherapy efficacy in patients with lung squamous cell carcinoma. Zhan X; Li J; Ding Y; Zhou F; Zeng R; Lei L; Zhang Y; Feng A; Qu Y; Yang Z Clin Exp Med; 2024 Jul; 24(1):145. PubMed ID: 38960987 [TBL] [Abstract][Full Text] [Related]
14. Deciphering a cell death-associated signature for predicting prognosis and response to immunotherapy in lung squamous cell carcinoma. Mao G; Yang D; Liu B; Zhang Y; Ma S; Dai S; Wang G; Tang W; Lu H; Cai S; Zhu J; Yang H Respir Res; 2023 Jul; 24(1):176. PubMed ID: 37415224 [TBL] [Abstract][Full Text] [Related]
15. Construction of a prognostic model for lung squamous cell carcinoma based on immune-related genes. Pu J; Teng Z; Yang W; Zhu P; Zhang T; Zhang D; Wang B; Hu Z; Song Q Carcinogenesis; 2023 May; 44(2):143-152. PubMed ID: 36455238 [TBL] [Abstract][Full Text] [Related]
16. Development and validation of a novel immune-related prognostic model in lung squamous cell carcinoma. Liu Z; Wan Y; Qiu Y; Qi X; Yang M; Huang J; Zhang Q Int J Med Sci; 2020; 17(10):1393-1405. PubMed ID: 32624696 [No Abstract] [Full Text] [Related]
17. Comprehensive Analysis of Immune Implication and Prognostic Value of Zeng Y; Zhang Z; Chen H; Fan J; Yuan W; Li J; Zhou S; Liu W Front Oncol; 2021; 11():798425. PubMed ID: 35047409 [TBL] [Abstract][Full Text] [Related]
18. Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma. Ju Q; Zhao YJ; Ma S; Li XM; Zhang H; Zhang SQ; Yang YM; Yan SX J Cancer Res Clin Oncol; 2020 Jul; 146(7):1711-1723. PubMed ID: 32356177 [TBL] [Abstract][Full Text] [Related]
19. M7G-Related lncRNAs predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma. Pan J; Huang Z; Lin H; Cheng W; Lai J; Li J BMC Cancer; 2022 Nov; 22(1):1132. PubMed ID: 36333719 [TBL] [Abstract][Full Text] [Related]
20. Distinct Patterns of mRNA and lncRNA Expression Differences Between Lung Squamous Cell Carcinoma and Adenocarcinoma. Tian Y; Yu M; Sun L; Liu L; Wang J; Hui K; Nan Q; Nie X; Ren Y; Ren X J Comput Biol; 2020 Jul; 27(7):1067-1078. PubMed ID: 31750732 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]